Kanabo Group Plc announced the appointment of Gil Efron to the Company's Board as a non-executive director,with effect from March 21st, 2022. Kanabo's Audit Committee is currently chaired by Uzi Danino, who will retire as a Non-Executive Director to focus on his other business interests. Gil will take over as chair of the Audit Committee following Uzi's retirement.

Gil is serving as President and Chief Financial Officer of NASDAQ and TASE dual-listed Purple Biotech Ltd., a clinical-stage company (PPBT) since June 2021, having previously held the position of Deputy Chief Executive Officer and Chief Financial Officer from October 2018.